Table 1.
Condition | POE Mechanism |
Specific POE Effect | Phenotype | Selected References |
---|---|---|---|---|
Transient neonatal diabetes mellitus |
Paternally imprinted chromosome 6q24 |
Paternal duplication or paternal UPD of chromosome 6q24, methylation defect of maternal ZAC/HYMAI |
Diabetes mellitus occurring before one week of age and resolving by three months |
Temple and Shield (2002) [22] Mackay et al (2005) [27] |
Beckwith- Wiedemann syndrome |
Imprinted chromosome 11p15.5 |
Complex variety of mechanisms including maternal germline CDKN1C mutations, mosaic paternal UPD 11p15.5, loss of maternal imprinting of IGF2, loss of maternal expression of H19, deletion of paternal LIT1 |
Numerous features including overgrowth, macroglossia, abdominal wall defects, embryonic tumors |
Engel et al (2000) [67] Niemitz et al (2004) [68] |
Prader-Willi syndrome |
Imprinted chromosome 15q11-13 |
Paternal deletion 15q11- 13, maternal UPD 15q11- 13, imprinting defect 15q11-13 |
Neonatal hypotonia/failure to thrive, hyperphagia, obesity, hypogonadisim, short stature, small hands/feet, mild mental retardation |
Nicholls et al (1998) [69] |
Angelman syndrome | Imprinted chromosome 15q11-13 |
Maternal deletion 15q11- 13, paternal UPD 15q11- 13 (rare), imprinting defect 15q11-13 |
Ataxia, tremor, seizures, sleep disorder, severe mental retardation, happy/laughing affect |
Nicholls et al (1998) [69] |
Albright hereditary osteodystrophy |
Paternally imprinted chromosome 20q13 |
GNAS1 mutation; maternally transmitted AHO cases additionally have multiple hormone resistance due to tissue- specific paternal GNAS1 imprinting |
Short stature, obesity, developmental delay, skeletal abnormalties ± multiple hormone resistance |
Weinstein et al (2001) [70] |
Russell-Silver syndrome (approximately 10% of cases) |
Maternally imprinted chromosome 7 |
Maternal UPD 7 | Short stature, asymmetry, triangular face |
Hannula et al (2002) [71] |
Maternally inherited diabetes and deafness |
Maternal inheritance via mitochondrial genome |
Mitochondrial 3243 A➔ G mutation |
Early onset non- insulin requiring diabetes without obesity, neurosensory hearing loss |
Guillausseau et al (2001) [38] |
Maturity Onset Diabetes of the Young 2 (MODY2) and birthweight |
Maternal intrauterine effects |
Maternal glucokinase (GCK) mutation associated with gestational diabetes mellitus and high offspring birth weight, fetal GCK mutation associated with low birth weight, maternal/fetal concordance for GCK mutation associated with normal birth weight |
MODY2: Modestly elevated fasting blood glucose, susceptibility to gestational diabetes and diabetes with minimal complications |
Hattersley et al (1998) [34] |